GlassScriptPhysician profile
Benjamin R Mchone
NPI 1437188232
$1,432.00
in general payments reported to CMS, 2019-2025
22 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $135 · 2022: $162 · 2023: $507 · 2024: $47.31 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.41 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $267.55 | 2025 | |
| Coloplast Corp | $191.74 | 2023-2024 | Coloplast Tfl Drive |
| Teleflex LLC | $170.54 | 2023 | Urolift |
| Astellas Pharma US INC | $111.73 | 2019-2020 | |
| Accord Healthcare, INC. | $106.28 | 2023 | |
| Procept Biorobotics Corporation | $100.72 | 2022 | |
| Neotract INC. | $79.85 | 2019-2020 | |
| Medtronic, INC. | $57.97 | 2022-2025 | Altaviva |
| Ethicon US, LLC | $39.94 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Dendreon Pharmaceuticals LLC | $34.86 | 2019 | |
| Olympus America INC. | $28.53 | 2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $27.46 | 2019 | |
| Sumitomo Pharma America, INC. | $24.03 | 2023 | Orgovyx |
| Boston Scientific Corporation | $23.50 | 2023 | Lithovue |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $23.08 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.44 | 2025 | |
| Abbvie INC. | $21.24 | 2019 | |
| Myriad Genetic Laboratories, INC. | $19.44 | 2024 | Prolaris |
| Telix Pharmaceuticals | $18.52 | 2023 | Illuccix |
| Pfizer INC. | $16.24 | 2019 | |
| Medtronic USA, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mchone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.